Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2006
08/24/2006WO2004110698A3 Methods and systems for processing microfeature workpieces with flow agitators and/or multiple electrodes
08/24/2006WO2004043397A3 Compositions and methods for the treatment of rheumatoid arthritis
08/24/2006WO2003087300A3 Secreted proteins
08/24/2006WO2003070193A3 RNA interference mediated inhibition of HIV gene expression using short interfering nucleic acid (siNA)
08/24/2006US20060191044 DNA comprises the nucleotide sequences used for gene expression of foreign proteins in seeds; genetic engineering
08/24/2006US20060191043 Low maintenance turfgrass
08/24/2006US20060191042 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
08/24/2006US20060191041 DWF4 polynucleotides, polypeptides and uses thereof
08/24/2006US20060191040 For altering trehalose-6-phosphate phosphatase activity in a plant; for temporal and spatial expression in transgenic plants to alter plant morphology and affect yield in plants; stress tolerance
08/24/2006US20060191039 Methods and compositions for protein production in tobacco plants with reduced nicotine
08/24/2006US20060191038 A promoter molecule that functions in plants, linked to an artificial polynucleotidemolecule that encodes a chloroplast transit peptide, linked to a heterologous glyphosate resistant 5-enolpyruvyl-3-phosphoshikimate synthase, linked to a transcriptiontermination signal region; glyphosate tolerance
08/24/2006US20060191037 Plant transcription factor that is involved in sugar signalling
08/24/2006US20060191036 Growing a tobacco plant having cells that contain an exogenous DNA sequence that encodes quinolate phosphoribosyl transferase functional in the cells
08/24/2006US20060191035 Methods and compositions for protein production in tobacco plants with reduced nicotine
08/24/2006US20060191034 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
08/24/2006US20060191033 Novel glyphosate-N-acetyltransferase (GAT) genes
08/24/2006US20060191032 Soybean cultivar 4713487
08/24/2006US20060191031 Soybean cultivar 4348019
08/24/2006US20060191030 Soybean cultivar S040122
08/24/2006US20060191029 Method and system for fusion and activation following nuclear transfer in reconstructed embryos
08/24/2006US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof
08/24/2006US20060191025 Method for the rapid selection of homozygous primary cell lines for the production of transgenic animals by somatic cell nuclear transfer
08/24/2006US20060191024 Method for preparing anti-MIF antibodies
08/24/2006US20060190191 Systems and methods for evaluating the significance of differences in biological measurements
08/24/2006US20060189798 Novel steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor
08/24/2006US20060189793 Methods and compositions for inhibiting neoplastic cell growth
08/24/2006US20060189792 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
08/24/2006US20060189791 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof
08/24/2006US20060189785 Using biocompatible, low molecular weighty, water solubler polymer; injectable
08/24/2006US20060189564 Direct delivery of inhibitory nucleic acid molecules to perispinal region or intrathecal space of spinal cord utilizing catheter and drug pump
08/24/2006US20060189563 Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
08/24/2006US20060189561 RNAi expression constructs with liver-specific enhancer/promoter
08/24/2006US20060189560 Molecular method to augment RNA mediated gene silencing
08/24/2006US20060189558 Delivery of substances to cells
08/24/2006US20060189557 increasing the sensitivity of a cell or tissues to cytotoxic cancer therapy with a naturally occurring nucleic acids
08/24/2006US20060189553 Drug delivery of polynucleotide to primate hepatocyte; high level of gene expression with transient increases in liver enzymes
08/24/2006US20060189550 Immunostimulatory, Covalently lipidated oligonucleotides
08/24/2006US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
08/24/2006US20060189531 Thrombopoietic compounds
08/24/2006US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences
08/24/2006US20060189525 DADD, death activator death domain protein
08/24/2006US20060189001 Ssx-2 peptides presented by hla class II molecules
08/24/2006US20060188993 Method of truncating both ends of a large piece of DNA
08/24/2006US20060188992 Electroporation method including the use of depressurization/pressurization
08/24/2006US20060188991 Flexible vaccine assembly and vaccine delivery platform
08/24/2006US20060188990 Novel prostate tumor-specific promoter
08/24/2006US20060188989 Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders
08/24/2006US20060188988 Optimized high yield synthetic plasmids
08/24/2006US20060188987 Targeted deletion of cellular DNA sequences
08/24/2006US20060188986 Restoration of methylation states in cells
08/24/2006US20060188981 MN gene and protein
08/24/2006US20060188976 Mutant protein having the peptide-synthesizing activity
08/24/2006US20060188973 3'-phosphoadenosine-5'-phosphosulfate synthetase 1 (PAPSS1) sequence variants
08/24/2006US20060188972 Targeted modification of chromatin structure
08/24/2006US20060188967 Method for extracting DNA from organisms
08/24/2006US20060188964 Processing for producing and crystallizing G-protein coupled receptors
08/24/2006US20060188963 Collectin-complement activating protein chimeras
08/24/2006US20060188962 19 human secreted proteins
08/24/2006US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
08/24/2006US20060188956 Relaxin3-gpcr135 complexes and their production and use
08/24/2006US20060188944 Methods of assaying receptor activity
08/24/2006US20060188919 Nucleic acid sequences having characteristics of enhanced expression in human neuroblastoma with favorable prognosis based on comparison between human neuroblastoma with favorable prognosis and human neuroblastoma with unfavorable prognosis
08/24/2006US20060188918 Hybridization method and hybridization equipment
08/24/2006US20060188915 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis
08/24/2006US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds
08/24/2006US20060188901 labelling nucleotides using terminal transferases, polymerases or a reverse transcriptase; sequence determination
08/24/2006US20060188900 High speed nucleic acid sequencing
08/24/2006US20060188893 Rolling circle amplification of RNA
08/24/2006US20060188888 Method of screening for improved specific activity of enzymes
08/24/2006US20060188881 Performing PCR using a sense primer and an antisense primer, in the presence of an additional sense primer comprising the sense primer and an oligodeoxyribonucleotide having a first additional sequence and ligated to the 5' end of the sense primer and an additional antisense primer
08/24/2006US20060188876 Binding a target substance
08/24/2006US20060188872 Novel post-transcriptional regulatory elements and uses thereof
08/24/2006US20060188577 Element having bioactive substance fixed thereto
08/24/2006US20060188560 Delivery system for nucleic acids
08/24/2006US20060188522 Viral agents
08/24/2006US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells
08/24/2006US20060188517 Mycobacterial sulfation pathway proteins and methods of use thereof
08/24/2006US20060188516 Chlamydia trachomatis antigens
08/24/2006US20060188514 Products specific to pathogenic strains and their use as vaccines and in immunotherapy
08/24/2006US20060188512 Active immunization to generate antibodies to solble a-beta
08/24/2006US20060188510 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3
08/24/2006US20060188502 Nucleic acid encoding a chimeric, humanized or CDR-grafted antibody that binds and inhibits the activity of human IL-6
08/24/2006US20060188484 Virus vectors and methods of making and administering the same
08/24/2006US20060188483 Virus vectors and methods of making and administering the same
08/24/2006US20060188482 Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal
08/24/2006US20060188481 Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder
08/24/2006US20060188480 Viral vectors
08/24/2006US20060188479 Plasmid for tissue targeted treatment of tumors; antitumor agents
08/24/2006US20060188478 Glycosylated interferon
08/24/2006US20060188477 Use of interferon alpha 5 in the treatment of viral liver diseases
08/24/2006US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery
08/24/2006US20060188413 Fluidic methods and devices for parallel chemical reactions
08/24/2006US20060186037 Cartridge retaining mechanism for nucleic acid extracting apparatus
08/24/2006DE60115613T2 Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien Production of recombinant muteins of the blood coagulation factor viii in human cell lines
08/24/2006DE4192786B4 Masernvirus-Rekombinanter Pockenvirus-Impfstoff Measles virus recombinant poxvirus vaccine
08/24/2006DE102005008102A1 Polynucleotide useful for coating a nano velcro medical threads, comprising a mature form coded fragment/polypeptide derivative with derived amino acid sequence and a coding sequence
08/24/2006CA2601924A1 Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
08/24/2006CA2598570A1 Methods for producing proteins using hamster igf-1
08/24/2006CA2598535A1 Anti her2/neu antibody
08/24/2006CA2598522A1 Human monoclonal antibodies to prostate specific membrane antigen (psma)